Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Mar 27, 2024; 16(3): 823-832
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.823
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.823
Item | 1 month | 1 yr |
Number of patients | 28 | 28 |
Primary endpoint | ||
Hernia recurrence | 0 (0) | 0 (0) |
Secondary endpoints | ||
Length of stay | 2.1 d ± 1.2 d | NA |
Return to work | 8.3 d ± 3.0 d | NA |
Readmission | 3 (10.7) | 0 (0) |
Wound | 0 (0) | 0 (0) |
Mesh infection | 2 (7.1) | 0 (0) |
Gastrointestinal | 2 (7.1) | 0 (0) |
Surgical site infection | ||
Superficial | 0 (0) | NA |
Deep | 0 (0) | NA |
Seroma | 0 (0) | 0 (0) |
Hematoma | 0 (0) | NA |
Wound dehiscence | 0 (0) | NA |
Fistula | 2 (7.1) | 0 (0) |
Mechanical obstruction | 0 (0) | 0 (0) |
Mesh infection | 2 (7.1) | 0 (0) |
Mesh removal | 1 (3.6) | 0 (0) |
- Citation: Lake SP, Deeken CR, Agarwal AK. Reinforced tissue matrix to strengthen the abdominal wall following reversal of temporary ostomies or to treat incisional hernias. World J Gastrointest Surg 2024; 16(3): 823-832
- URL: https://www.wjgnet.com/1948-9366/full/v16/i3/823.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i3.823